Crown Place VCT PLC
Interim Management Statement
LEI Code: 213800SYIQPA3L3T1Q68
Introduction
I am pleased to present Crown Place VCT PLC’s interim management statement for the period from 1 January 2022 to 31 March 2022.
Performance and dividends
The Company’s unaudited net asset value (NAV) as at 31 March 2022 was £86.0 million or 33.71 pence per share (excluding treasury shares). After accounting for a dividend of 0.84 pence per share which was paid on 31 March 2022 to shareholders on the register on 11 March 2022 the NAV has increased by 0.79 pence per share (2.4 per cent.) since 31 December 2021.
Fundraising and share issues
During the period from 1 January 2022 to 31 March 2022, the Company issued the following new Ordinary shares of nominal value 1 penny per share under the Albion VCTs Prospectus Top Up Offers 2021/22:
| Date | Number of shares issued | Issue price per share (including costs of issue) | Net proceeds £’000 |
| 25 February 2022 | 30,665,580 | 34.30p to 34.70p | 10,374 |
| 31 March 2022 | 1,838,353 | 33.80p | 606 |
On 2 March 2022, the Company announced that applications under the Prospectus offer had reached its £12 million gross limit and was therefore fully subscribed and closed to further applications.
The Company also issued the following shares under the dividend reinvestment scheme which are included in the net asset value figures for 31 March 2022 above:
| Date | Number of shares issued | Issue price per share | Net invested £’000 |
| 31 March 2022 | 1,137,670 | 32.92 pence | 357 |
The Company continues to offer a Dividend Reinvestment Scheme to existing shareholders. Details of this Scheme can be found at www.albion.capital/funds/CRWN.
Portfolio
The following investments have been made during the period from 1 January 2022 to 31 March 2022:
| New investments | £’000 | Activity |
| Perchpeek Limited | 672 | Digital relocation platform |
| Regulatory Genome Development Limited | 116 | Provider of machine readable structured regulatory content |
| Total further investments | 788 |
| Further investments | £’000 | Activity |
| TransFICC Limited | 846 | A provider of a connectivity solution, connecting financial institutions with trading venues via a single API |
| Seldon Technologies Limited | 615 | Software company that enables enterprises to deploy Machine Learning models in production |
| Cantab Research Limited (T/A Speechmatics) | 445 | Provider of low footprint automated speech recognition which can be deployed in the cloud, on premise or on device across over 31 languages |
| Black Swan Data Limited | 336 | Predictive analytics for consumer brands |
| Nuvoair Holdings Inc. | 152 | Digital therapeutics and decentralised clinical trials for respiratory conditions |
| Koru Kids Limited | 83 | Online marketplace connecting parents and nannies |
| Locum's Nest Limited | 82 | Provides a technology solution for the management of locum doctors for the NHS |
| Total further investments | 2,559 |
Disposals
The following disposals were made during the period from 1 January 2022 to 31 March 2022:
| Portfolio Company | £000s | |
| Credit Kudos Limited | 2,352 | Disposal of investment on a cost of £0.5 million realising a gain of £1.9 million on cost |
| Phrasee Limited | 1,991 | Disposal of investment on a cost of £0.6 million realising a gain of £1.4 million on cost |
| MyMeds&Me Limited | 1,476 | Disposal of investment on a cost of £0.5 million realising a gain of £1.0 million on cost |
| Total proceeds | 5,819 |
Top ten holdings as at 31 March 2022:
| Investment | Carrying value £’000 | % of net asset value | Activity |
| Quantexa Limited | 10,119 | 11.8 | Network analytics platform to detect financial crime |
| Proveca Limited | 3,993 | 4.6 | Reformulation of paediatric medicines |
| Oviva AG | 3,634 | 4.2 | Technology enabled service business in medical nutritional therapy (MNT) |
| Chonais River Hydro Limited | 3,276 | 3.8 | Owner and operator of a 2 MW hydro-power scheme in the Scottish Highlands |
| Radnor House School (TopCo) Limited | 3,145 | 3.7 | Independent school for children aged 2-18 |
| The Evewell Group Limited | 2,415 | 2.8 | Operator and developer of women’s health centres focusing on fertility |
| Cantab Research Limited (T/A Speechmatics) | 1,923 | 2.2 | Provider of low footprint automated speech recognition which can be deployed in the cloud, on premise or on device across 31 languages |
| Gharagain River Hydro Limited | 1,793 | 2.1 | Owner and operator of a 1 MW hydro-power scheme in the Scottish Highlands |
| Elliptic Enterprises Limited | 1,529 | 1.8 | Provider of Anti Money Laundering services to digital asset institutions |
| Black Swan Data Limited | 1,355 | 1.6 | Predictive analytics for consumer brands |
Share buy-backs
During the period from 1 January 2022 to 31 March 2022, the Company purchased 2,022,762 shares for £636,000 including stamp duty, at an average price of 31.27 pence per share. All of the shares are to be held in treasury.
It remains the Board’s policy to buy back shares in the market, subject to the overall constraint that such purchases are in the Company’s interest, including the maintenance of sufficient resources for investment in existing and new portfolio companies and the continued payment of dividends to shareholders.
It is the Board’s intention for such buy-backs to be at around a 5 per cent. discount to net asset value, so far as market conditions and liquidity permit.
Material events and transactions after the period end
After the period end, the Company undertook the following material investment transaction:
- Investment of £532,000 in an existing portfolio company, Gravitee Topco Limited, an open source API management platform.
The following new Ordinary shares of nominal value 1 penny each were allotted under the Albion VCTs Prospectus Top Up Offers 2021/22 to shareholders who elected for the 2022/23 tax year:
| Date | Number of shares issued | Issue price per share (including costs of issue) | Net proceeds £’000 |
| 11 April 2022 | 2,215,278 | 33.50p to 33.80p | 730 |
There have been no other material events or transactions after the period end to the date of this announcement.
Further information
Further information regarding historic and current financial performance and other useful shareholder information can be found on the Company’s webpage on the Manager’s website at www.albion.capital/funds/CRWN.
Penny Freer, Chairman
crownchair@albion.capital
17 May 2022
For further information please contact:
Vikash Hansrani
Operations Partner
Albion Capital Group LLP
Telephone: 020 7601 1850
